HC directs Puducherry govt to decide on probe against official

Image
Press Trust of India Chennai
Last Updated : Nov 10 2016 | 4:42 PM IST
The Madras High Court has directed the Puducherry government to take a decision on reconstituting an inquiry committee to look into charges against an official of the Department of Drugs Control, who was reported as 'unfit' by CBI for the post of Drugs Inspector.
The court gave the directions yesterday on a PIL by V Manikandan, an MLA of Puducherry Assembly.
The PIL sought a direction to the Chief Secretary of the Puducherry administration to quash the Government Order constituting an inquiry committee to probe the charges against the Assistant Commissioner, Department of Drugs Control, Baalassoupramanien, and reconstitute it.
The court said, "The representation of the petitioner for reconstitution of the Committee, in the form of this petition, be examined by Government of Puducherry and a decision taken on the same and communicated to the petitioner in one month."
Manikandan submitted he had raised the issue of alleged closure of nearly 150 drug companies in Puducherry, in the recent past due to "torture" and corrupt practises of the official, who was then Drug Inspector. He was later promoted as Assistant Commissioner, which is not a sanctioned post.
Referring to the CBI report on the officer, which stated he was unfit for the post of Drug Inspector, the petitioner alleged the promotion was given to the officer even without obtaining a vigilance clearance.
He alleged that the Under Secretary to Health Department, who is facing several charges and another Group B officer and a subordinate to the 'delinquent' officer, were nominated as members of the Enquiry Committee, which was illegal.
Manikandan submitted that he had already made a representation to the Chief Minister in this regard on November 21, but to no avail.
Hence, he moved the court seeking a direction to set aside the order of appointment of the Committee and to reconstitute it.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 10 2016 | 4:42 PM IST

Next Story